CSO at BioResearch Pharma SA, Professor of Health Sciences at Medical University of Warsaw
Repurposing of known medications beyond their original therapeutic indications is an increasingly attractive drug development path. Offering a cost-effective and time-efficient approach, this strategy is not a challenge-free process: issues related to intellectual property, drug formulation barriers or funding need to be surpassed. Successfully facing these challenges, BioResearch Pharma SA aims to provide new treatment options for dermatology patients. The company pipeline features drug repurposed candidates for psoriasis and androgenetic alopecia. Effective topical dermatology treatments can improve the quality of life for many patients. #pharma #dermatology
It is worth noting, that repurposing of medications in some circumstances can lead to „a second medical use” suitable for patent protection.
Professor of Multidisciplinary Research & Graduate Education
10moMerck, the big pharma company has been recycling Keytrua for 14 types of cancer. Drug repurposing has been the bread and butter for such a giant!